Serum Metabolomics Identifies Dysregulated Pathways and Potential Metabolic Biomarkers for Hyperuricemia and Gout.

Xia ShenCan WangNingning LiangZhen LiuXinde LiZheng-Jiang ZhuTony Raymond Merriman Nicola DalbethRobert TerkeltaubChanggui Li Hui-Yong Yin

Published in: Arthritis & rheumatology (Hoboken, N.J.) (2021)

Gout and hyperuricemia have distinct serum metabolomic signatures. This diagnostic model has the potential to improve current gout care through early detection or prediction of progression to gout from hyperuricemia.

Keyphrases

uric acid
metabolic syndrome
genome wide
healthcare
mass spectrometry
palliative care
human health
gene expression
risk assessment
dna methylation
pain management
affordable care act